VijayBabuA

Wait for breakout

VijayBabuA 已更新   
NSE:STAR   STRIDES PHARMA SCI
path desider
評論:
it has crossed resistance with increased volumes following up day also has seen increased volume. initial target will be 396, 400 ( which is 200 DMA).

免責聲明

這些資訊和出版物並不意味著也不構成TradingView提供或認可的金融、投資、交易或其他類型的意見或建議。請在使用條款閱讀更多資訊。